Investigational Device Exemptions

Tools

US vs. Outside US Trials: Date: 7/27/2011; Length: 1 minutes; Speaker(s): Howard Holstein; Sources: Stanford Biodesign; Description: Paul Yock interviews Howard Holstein, regulatory attorney, on investigational Device Exemptions: Question 2: Must trials occur in the U.S.?

Need for Meeting with FDA Prior to IDE: Howard Holstein; 7/28/2011; Summary: Paul Yock interviews Howard Holstein, regulatory attorney, on investigational Device Exemptions: Question 5: What advice do you have for an innovator prior to meeting with the FDA in the IDE process? Watch More
Need for Clinical Trials: Howard Holstein; 7/27/2011; Summary: Paul Yock interviews Howard Holstein, regulatory attorney, on investigational Device Exemptions: Question 1: Are clinical trials always needed before getting clearance or approval from the FDA?
Watch More
Need for Meeting with FDA Prior to IDE: Howard Holstein; 7/27/2011; Summary: Paul Yock interviews Howard Holstein, regulatory attorney, on investigational Device Exemptions: Question 4: Should a company always meet with the FDA before launching an IDE process?
Watch More
Role of Investigational Device Exemption: Howard Holstein; 7/27/2011; Summary: Paul Yock interviews Howard Holstein, regulatory attorney, on investigational Device Exemptions: Question 3: What is the role of an IDE and initiating that process?
Watch More
US vs. Outside US Trials: Howard Holstein; 7/27/2011; Summary: Paul Yock interviews Howard Holstein, regulatory attorney, on investigational Device Exemptions: Question 2: Must trials occur in the U.S.?
Watch More

Name: Email: Comment:

Submit

Search Forum Search Term Topic Search

Email Newsletter Signup Sign Up

Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.